ESC 365 - QUORUM : Quantum Genomics Firibastat (QGC001) or Ramipril after Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction

Open Access

QUORUM : Quantum Genomics Firibastat (QGC001) or Ramipril after Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction

Session: Late Breaking Trials in ACS

Topic: Pharmacotherapy

Speaker: Professor G. Montalescot (Paris, FR)

Event: ESC Congress 2021 - The Digital Experience

Congress Session

About the speaker

Professor Gilles Montalescot

Sorbonne University, Paris (France)

24 presentations

1 follower

3 more presentations in this session

HUYGENS: Evolocumab and changes in plaque composition on OCT

Speaker: Professor S. Nicholls (Melbourne, AU)

ACCOST-HH: Adrecizumab in cardiogenic shock

Speaker: Doctor M. Karakas (Hamburg, DE)

Low-dose rivaroxaban during the acute phase of ACS - H-REPLACE Trial)

Speaker: Professor S. Zhou (Changsha, CN)

Access the full session

Late Breaking Trials in ACS

Speakers: Professor G. Montalescot, Professor S. Nicholls, Doctor M. Karakas, Professor S. Zhou

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

This platform is supported by